Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deckers Outdoor Corp (DECK) vs Zoetis Inc (ZTS) Price & Performance

Deckers Outdoor CorpTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Deckers Outdoor Corp vs Zoetis Inc — how do they compare? Deckers Outdoor Corp trades at $94.19 (market cap $13.27B), while Zoetis Inc trades at $75.36 (market cap $30.92B). The key difference: Zoetis Inc is far larger — about 2.3× Deckers Outdoor Corp's market cap, and Zoetis Inc pays a 2.83% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals.

DECKZTS
Market Cap
$13.27B$30.92B
Sector
Consumer CyclicalHealth
52-Week High
$123.91$156.76
52-Week Low
$79.54$71.91
Enterprise Value
$12.14B$38.49B
Dividend Yield
2.83%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deckers Outdoor Corp

Deckers Outdoor (DECK) trades at $97.46, down 0.42% with bearish technical signals but strong fundamentals. The company reported consistent earnings beats with Q1 2026 EPS of $0.96 beating expectations of $0.81. Revenue grew to $4.99 billion in 2025 with impressive 18.36% net margin and 42.56% ROE. Analyst consensus remains positive with 45% buy ratings and $122.40 price target, though recent guidance concerns caused a 6% selloff.

DECK offers compelling value with a 13.86 P/E ratio below industry averages, supported by HOKA and UGG brand strength. Key risks include tariff headwinds, brand concentration, and execution challenges. The stock presents a growth opportunity at current levels but faces near-term volatility from macroeconomic pressures and competitive dynamics in the apparel sector.

Zoetis Inc

Zoetis (ZTS) trades at $72.66, down 5.92% amid a bearish technical signal and recent earnings pressure. The stock is near its 52-week low after Piper Sandler cut its price target to $80.00 on August 11, 2026. Despite strong profitability with a net margin of 27.69% and ROE of 64.91%, Q2 2026 revenue missed estimates, and the company reduced its 2026 outlook due to softer pet healthcare demand. Cash flow improved in 2025 with net cash flow of $325 million, but debt-to-asset ratio remains elevated at 46.14%.

The outlook is cautious with near-term headwinds in companion animal markets, but long-term fundamentals remain solid given the company's leading position in animal health. Risks include competitive pressures and a class action lawsuit. Analyst consensus is a Buy with a $95.00 price target, implying significant upside if execution improves.

Returns comparison

Trailing returns across standard periods

About Deckers Outdoor Corp

Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.

Read more on DECK

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS